INTRODUCTION
Gene expression is robustly regulated at the posttranscriptional level by RNA-binding proteins (RBPs) and by noncoding RNAs (ncRNAs). Small ncRNAs, particularly microRNAs (miRNAs), partially base pair with specific target mRNAs and repress their expression by lowering mRNA stability and/or translation (Chekulaeva and Filipowicz, 2009; Guo et al., 2010) . Gene repression by miRNAs is accomplished through the recruitment of RNA-induced silencing complex (RISC) components such as argonaute 2 (Ago2), which cleaves target mRNA, and Rck/ p54, which facilitates the formation of cytoplasmic processing bodies (PBs), remodels mRNA-associated ribonucleoprotein complexes (mRNPs), and influences mRNA translation, storage, and degradation (Weston and Sommerville, 2006; Chu and Rana, 2006; Bartel, 2009) . Long ncRNAs (lncRNAs) have been implicated in numerous gene transcription processes, as indicators of transcription factor activity, decoys that titrate away RBPs, functional guides for RNP complexes, and scaffolds for the assembly of functionally related proteins like transcriptional regulators (Wang and Chang, 2011) . LncRNAs have also been reported to participate in a limited number of posttranscriptional processes: the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was implicated in splicing, the cytoplasmic half-Staufen 1-binding site lncRNAs (1/2-sbsRNAs) was implicated in Staufen 1-mediated mRNA decay, and an antisense lncRNA (BACE1-AS) interacts with and stabilizes the mRNA encoding the enzyme BACE1 (Faghihi et al., 2008; Tripathi et al., 2010; Gong and Maquat, 2011) .
Recently, photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) analysis (Mukherjee et al., 2011) revealed that the RBP HuR associates with many mRNAs in human cervical carcinoma HeLa cells ($75% of PAR-CLIP RNA tags), and with numerous ncRNAs ($25% of tags, identified as described by Cabili et al., 2011) . Among these, the vast majority were lncRNAs, including lincRNA-p21, MALAT1, NEAT1, and lncRNAs involved in X chromosome inactivation (Cabili et al., 2011; Mukherjee et al., 2011) . HuR is a ubiquitous RBP that influences cell proliferation, survival, carcinogenesis, and the stress and immune responses. HuR performs these functions mainly by associating with subsets of mRNAs and increasing their stability and/or modulating their translation (Hinman and Lou, 2008; Abdelmohsen and Gorospe, 2010) . For a few HuR target mRNAs, HuR affects mRNA stability and translation by competing or cooperating with mRNA decaypromoting RBPs (e.g., AUF1, TTP [Lal et al., 2004; Young et al., 2009] ) and with miRNAs (e.g., miR-122, let-7 [Bhattacharyya et al., 2006; Kim et al., 2009] ). However, for most target mRNAs, the molecular effectors of HuR's posttranscriptional influence are unknown. S1A-S1C). We sought to investigate this interaction further, given the role of HuR and lincRNA-p21in the stress response (Abdelmohsen and Gorospe, 2010; Huarte et al., 2010) . As shown, lincRNA-p21 was strongly enriched in anti-HuR IP reactions and in control anti-hnRNP K IP reactions (Huarte et al., 2010) , but not in anti-AUF1 IP reactions ( Figure 1A ). HuR-lincRNA-p21 interactions were also detected in mouse cells ( Figures S1D and S1E) .
We hypothesized that HuR might stabilize lincRNA-p21, as HuR stabilizes many mRNAs (Hinman and Lou, 2008) . Fortyeight hours after silencing HuR using small interfering RNA (siRNA) in HeLa cells, we measured the steady-state lincRNAp21 levels, as well as the lincRNA-p21 half-life after inhibiting transcription by incubating cells with actinomycin D and measuring the rate of lincRNA-p21 clearance using RT-qPCR. Contrary to prediction, lincRNA-p21 levels were higher and its half-life longer in HuR-silenced cells (t 1/2 $3 hr) than in control cells (t 1/2 $1.2 hr) ( Figure 1B ), indicating that HuR destabilized the lincRNA-p21. Accordingly, lincRNA-p21 expression levels were significantly higher in mouse embryonic fibroblasts (MEFs) derived from a mouse lacking both HuR alleles (HuR Figure S2A ) (Katsanou et al., 2009 ). These results indicate that HuR enhances lincRNA-p21 decay.
Given earlier evidence that HuR suppressed target c-Myc mRNA expression by facilitating its interaction with let-7/RISC (Kim et al., 2009 ), we examined whether a similar repression mechanism controlled lincRNA-p21 levels. Mouse lincRNA-p21 was predicted to associate with several miRNAs, with let-7 showing a prominent effect among them (Figures S2B and S2C) . These interactions appeared to be functional, as MEFs deficient in Ago2, a necessary component of let-7/RISC (Cheloufi et al., 2010) , displayed higher lincRNA-p21 levels ( Figure S2D ). In HeLa cells, Ago2 RIP analysis showed robust enrichment in lincRNA-p21 ( Figure 1C ), while transfection of biotinylated precursor let-7b (pre-let-7b) followed by pull-down analysis of bound endogenous target mRNAs using streptavidin beads and RT-qPCR analysis (Lal et al., 2011 ) revealed a marked enrichment in lincRNA-p21 compared with a control transcript (GAPDH mRNA), but not in pull-downs using nonbiotinylated control pre-let-7b ( Figure 1D ). These interactions affected lincRNA-p21 stability, as its half-life was higher after Ago2 silencing (t 1/2 $3 hr) and was lower after overexpressing prelet-7b (t 1/2 $0.9 hr) ( Figure 1E ). Collectively, these data indicate that HuR and let-7/Ago2 lower lincRNA-p21 stability.
As assessed by RIP analysis, silencing Ago2 in HeLa cells reduced the interaction of HuR with lincRNA-p21, while silencing HuR lowered the interaction of Ago2 with lincRNA-p21 ( Figures  1F and 1G) . Overexpression of Flag-tagged HuR significantly reduced lincRNA-p21 levels but did not reverse the elevated lincRNA-p21 levels observed after inhibition of endogenous let-7 using an antagomir (AS-let-7b) ( Figure 1H ). Together with evidence that the heightened lincRNA-p21 after HuR silencing was prevented by overexpressing pre-let-7 ( Figure 1I ), and that mutating let-7 sites can block the HuR-elicited repression ( Figure S1C ), our findings suggest that HuR and let-7/Ago2 repress lincRNA-p21 expression cooperatively, and that HuR and let-7/Ago2 binding to lincRNA-p21 is crucial for lincRNAp21 decay.
LincRNA-p21 Selectively Interacts with Target CTNNB1 and JUNB mRNAs LincRNA-p21 was moderately more abundant in the cytoplasm than in the nucleus of fractionated HeLa cells, and its levels increased proportionately after silencing HuR (Figure 2A ). LincRNA-p21 subcellular localization was further analyzed by tagging lincRNA-p21 with MS2 RNA hairpins, tracked intracellularly by fluorescent fusion protein MS2-YFP (Bertrand et al., 1998; Lee et al., 2010 ; Figure S3A ). We postulated that this distribution could impact upon cytoplasmic gene regulatory events and further hypothesized that lincRNA-p21 might elicit some of HuR's effects on target mRNAs.
To test these possibilities, we focused on mRNAs encoding b-catenin (CTNNB1) and JunB (JUNB), identified as being translationally repressed after HuR was silenced (Ló pez de Silanes et al., 2003; Lebedeva et al., 2011) . Several regions of high complementarity with lincRNA-p21 were identified for CTNNB1 mRNA (15 sites) and for JUNB mRNA (8 sites), but only 2 for GAPDH mRNA ( Figure 2B ; Table S1 ). In HeLa cells, the interaction of endogenous lincRNA-p21 with CTNNB1 and JUNB mRNAs was quantified by affinity pull-down of endogenous lincRNA-p21 using a biotinylated RNA antisense to lincRNAp21 (Experimental Procedures). As shown in Figure 2C , CTNNB1 and JUNB mRNAs showed significantly greater interaction with lincRNA-p21 than GAPDH mRNA (used for normalization of sample input) and 18S rRNA (used as reference for enrichment). Similarly, biotinylated mouse lincRNA-p21 incubated with MEF lysates, followed by RNA extraction and detection by RT-qPCR, revealed its selective interaction with mouse ctnnb1 and junb mRNAs ( Figures S3B and S3C) ; conversely, in vitro-transcribed unlabeled lincRNA-p21 was selectively pulled down using biotinylated mouse ctnnb1and junb RNAs ( Figure S3D ).
Lowering HuR in HeLa cells decreased b-catenin and JunB levels, as assessed by western blotting ( Figure 2D ). Strikingly, however, simultaneous silencing of lincRNA-p21 by using a specific siRNA that lowered lincRNA-p21 levels to $40%-45% of the levels seen in Ctrl siRNA cells ( Figure 2E ) and preferentially silenced cytoplasmic lincRNA-p21 ( Figure S3F ) prevented the decline in b-catenin and JunB levels ( Figure 2D ). Simply silencing lincRNA-p21 or Ago2 in HeLa cells did not affect b-catenin or JunB levels ( Figure S3G ), supporting the notion that repression required HuR silencing. These effects were not due to changes in CTNNB1 or JUNB mRNA levels ( Figure 2F ), nor were they due to changes in b-catenin or JunB protein stability (data not shown), suggesting that lincRNA-p21 likely reduced the translation of CTNNB1 and JUNB mRNAs.
LincRNA-p21 Associates with Translational Apparatus, Diminishes CTNNB1 and JUNB Polysomes To directly test the possibility that lincRNA-p21 may influence translation, HeLa cell lysates expressing different lincRNA-p21 and HuR levels were fractionated through sucrose gradients. The lightest components sedimented at the top (fractions 1 and 2), small (40S), and large (60S) ribosomal subunits and monosomes (80S) in fractions three to five, and progressively larger polysomes, ranging from low to high molecular weight (LMW, HMW), in fractions six to ten ( Figure 3A ). Silencing HuR and/or lincRNA-p21 did not change the polysome distribution profiles or eIF2a phosphorylation ( Figure 3A , Figure S4A ), indicating that these interventions did not affect global translation. After isolating RNA from each fraction, RT-qPCR analysis indicated that lincRNA-p21 was abundant in fractions six to nine; although silencing HuR elevated lincRNA-p21 levels overall, its distribution shifted toward smaller polysomes ( Figure 3B , top left). LincRNA-p21 associated with polysomes and did not simply cosediment with polysomes, as puromycin treatment, which disrupts polysomes, markedly shifted leftward the distribution of lincRNA-p21 ( Figure 3B, top right) . The polysomal sizes of CTNNB1 and JUNB mRNAs also shifted leftward after HuR Table S1 . (C) HeLa cell lysates were incubated with 5 0 end biotin-labeled antisense lincRNA-p21 oligo (lincRNA-p21 pull-down) and sense oligo (control pull-down); after pull-down, RNA was extracted and CTNNB1 and JUNB mRNAs, as well as normalization control 18S rRNA, were assessed by RT-qPCR.
(D and E) Forty-eight hours after transfecting HeLa cells with siRNAs, the levels of b-catenin, JunB, HuR, and HSP90 were assessed by WB analysis and densitometry (D), and lincRNA-p21 (E), CTNNB1, and JUNB mRNAs (F) were quantified by RT-qPCR. In (A) and (C)-(F), data represent the means and SD (error bars) from at least three independent experiments. Western blots in (A) and (D) are representative of three independent experiments.
silencing, in keeping with reduced translation ( Figure 3B , bottom). Interestingly, silencing lincRNA-p21 totally prevented the reduction in polysomes seen after silencing HuR ( Figure 3B , bottom), in agreement with the increased b-catenin and JunB abundance ( Figure 2E ). The distribution of the housekeeping GAPDH mRNA did not show this pattern (Figure 3B , bottom), indicating that silencing HuR siRNA and/or lincRNA-p21 specifically affected CTNNB1 and JUNB mRNAs. It remains to be determined whether other mRNAs are translationally repressed by lincRNA-p21 in this manner, as well as the fractions of JUNB and CTNNB1 mRNA pools that associate with lincRNA-p21. Finally, we investigated if lincRNA-p21 inhibited the translation of CTNNB1 and JUNB mRNAs by enhancing their interaction with translational repressors. By RIP analysis, the translational repressors Rck and FMRP were found to interact with lincRNA-p21 in HeLa cells ( Figure 4A ) and MEFs ( Figure S4B ). In HeLa lysates, Rck and FMRP (but not TIAR) also associated with MS2-tagged lincRNA-p21 (immobilized on beads via MS2-GST; Figure S4C ). Interestingly, the interaction of endogenous lincRNA-p21 with endogenous CTNNB1 and JUNB mRNAs in HeLa cells (measured as in Figure 2C ) was potently reduced if Rck was silenced ( Figure 4B ), indicating that Rck facilitated these interactions. A similar effect of Rck was seen with a tagged Molecular Cell lincRNA-p21 Represses Translation mouse lincRNA-p21 ( Figure S4D ). Conversely, when lincRNAp21 was silenced, Rck did not associate with CTNNB1 or JUNB mRNAs ( Figure 4C ). In turn, silencing Rck in HeLa cells reversed the inhibition of b-catenin and JunB expression seen after HuR silencing ( Figure 4D, top) ; lincRNA-p21 levels were not markedly changed by Rck silencing (Figure 4D, graph) . These findings indicated that the repression of b-catenin and JunB translation by lincRNA-p21 required Rck function (Chu and Rana, 2006) . Supporting this possibility, the decline in the sizes of polysomes associated with CTNNB1 and JUNB mRNAs after silencing HuR (previously attributed to the higher lincRNAp21 levels [ Figure 3B ]) was only seen when Rck was expressed ( Figures 4E and 4F ); lincRNA-p21 followed a similar distribution pattern ( Figure S4E ). Whether Rck reduces the translation of other mRNAs in a similar fashion remains to be studied.
Perspective: lincRNA-p21 Inhibits Translation of Target mRNAs
Based on these results, we propose that in the presence of HuR, lincRNA-p21 is unstable through the recruitment of let-7/Ago2. Figure 4G ). In the absence of HuR, lincRNA-p21 is stable and accumulates, and Rck promotes the association of lincRNA-p21 with CTNNB1 and JUNB mRNAs, repressing their translation through a mechanism that includes reduced polysome sizes ( Figure 4G ); in addition, base-pair interactions of lincRNA-p21 with target mRNAs may result in ribosome ''drop-off.'' In sum, HuR-dependent translation activation requires rapid degradation of lincRNA-p21 in order to prevent the recruitment of translation repressors onto target mRNAs. Similar regulation may affect other mRNAs whose translation increases by HuR (Abdelmohsen and Gorospe, 2010) . Through these regulatory processes, HuR can help implement a well-established pro-oncogenic, cell-protective program ( Figures  S4F and S4G ) which includes prosurvival proteins b-catenin and JunB (Shaulian, 2010; Fu et al., 2011) . With rising recognition that lncRNAs play pivotal roles in disease processes (Wapinski and Chang, 2011) , other proteins regulated by the orchestrated influence of RBPs, lncRNAs, and miRNAs are likely to emerge.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, Small Interfering RNAs, MicroRNAs, and Plasmids Human HeLa cells and MEFs were cultured in DMEM (Invitrogen) supplemented with 10% (v/v) FBS and antibiotics. All siRNAs, including control (Ctrl) siRNA (UUCUCCGAACGUGUCACGUdTdT), and siRNAs to lower lincRNA-p21 (CTGCAAGGCCGCATGATGAdTdT), HuR (CGUAAGUUAUUU CCUUUAAdTdT), Ago2, and Rck (sc-44409 and sc-72246, respectively, Santa Cruz Biotechnology), were transfected at 20 nM final concentration using Lipofectamine 2000 (Invitrogen) and analyzed 48 hr later. Pre-and AS-let-7b (Ambion) were transfected at 10 nM final concentration. The oligomers for affinity pull-down of endogenous human lincRNA-p21 (GGGTGGCTCACT CTTCTGGC [antisense] and GCCAGAAGAGTGAGCCACCC [sense] ) were biotinylated at the 5 0 end. Actinomycin D (Sigma) was used at 2.5 mg/ml. A plasmid expressing lincRNA-p21 (Huarte et al., 2010) , was used to construct plasmid plincRNA-p21-MS2. Plasmid pMS2-YFP was previously reported (Lee et al., 2010) ; pMS2-GST was a kind gift from J.A. Steitz.
Western Blot Analysis
Whole-cell lysates, prepared in RIPA buffer, were separated by SDSpolyacrylamide gel electrophoresis (SDS-PAGE), and transferred onto PVDF membranes (Invitrogen iBlot Stack). Primary antibodies recognizing b-catenin, JunB, a-tubulin, histone H1, HSP90, HuR, Rck, FMRP, GFP, eIF2a, and phospho-eIF2a were from Santa Cruz Biotechnology. Antibodies recognizing Ago2, MBP, AUF1, TIAR, and Flag were from Abcam, Cell Signaling Technology, Millipore, BD Biosciences, and Sigma, respectively. HRP-conjugated secondary antibodies were from GE Healthcare.
Immunoprecipitation Assays
For immunoprecipitation (IP) of endogenous RNP complexes from whole-cell extracts (Abdelmohsen et al., 2007) , cells were lysed in 20 mM Tris-HCl at pH 7.5, 100 mM KCl, 5 mM MgCl 2 , and 0.5% NP-40 for 10 min on ice and centrifuged at 10,000 3 g for 15 min at 4 C. The supernatants were incubated with protein A Sepharose beads coated with antibodies that recognized HuR, Rck, or FMRP (Santa Cruz Biotechnology), Ago2 (Abcam), or AUF1 (Millipore), or with control IgG (Santa Cruz Biotechnology) for 1 hr at 4 C. After the beads were washed with NT2 buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM MgCl 2 , and 0.05% NP-40), the complexes were incubated with 20 units of RNase-free DNase I (15 min at 37 C) and further incubated with 0.1% SDS/0.5 mg/ml Proteinase K (15 min at 55 C) to remove DNA and proteins, respectively. The RNPs isolated from the IP materials was further assessed by RT-qPCR analysis.
RNA Analysis
Trizol (Invitrogen) was used to extract total RNA and acidic phenol (Ambion) was used to extract RNA for RIP analysis (Abdelmohsen et al., 2007) . Reverse transcription (RT) was performed using random hexamers and reverse transcriptase (SSII, Invitrogen) and real-time, quantitative PCR (qPCR) using gene-specific primers (Table S2 ) and SYBR green master mix (Kapa Biosystems), using the Applied Biosystems 7300 instrument.
Biotin Pull-Down Assay
To synthesize biotinylated transcripts, PCR fragments were prepared using forward primers that contained the T7 RNA polymerase promoter sequence (Abdelmohsen et al., 2007) . Primers used to prepare biotinylated transcripts are listed below (Table S2 ). After purification of the PCR products, biotinylated transcripts were synthesized using MaxiScript T7 kit (Ambion) and whole-cell lysates (50 mg per sample) were incubated with 1 mg of purified biotinylated transcripts for 1 hr at 25 C; complexes were isolated with streptavidin-coupled Dynabeads (Invitrogen). The proteins present in the pull-down material were detected by western blot analysis and the RNA present in the pull-down material by RT-qPCR analysis. Biotinylated lincRNA-p21 was synthesized using T7 RNA polymerase and plasmid pcDNA3 lincRNA-p21 (Huarte et al., 2010) . Forward PCR primers contained the T7 RNA polymerase promoter sequence (CCAAGCTTCTAA TACGACTCACTATAGGGAGA [T7]). Primers used are listed in Table S2 .
For antisense oligomer pull-down, biotin-labeled DNA complementary to human lincRNA-p21 (0.5 mg) was incubated with HeLa cell lysates for 2 hr, and the complexes were isolated with streptavidin-coupled Dynabeads (Invitrogen).
Polysome Analysis
Forty-eight hours after transfection with siRNAs, HeLa cells were preincubated with cycloheximide (Sigma; 100 mg/ml for 15 min), and cytoplasmic lysates were prepared and fractionated by ultracentrifugation through 15%-60% linear sucrose gradients; ten fractions were collected, and RNA extracted from each fraction was used for RT-qPCR analysis, as described (Lee et al., 2010) .
Subcellular Fractionation
Cytosolic and nuclear fractions were collected as described previously (Lal et al., 2004) . Briefly, cells were lysed with a buffer containing 10 mM Tris-HCl (pH 7.4), 100 mM, NaCl, 2.5 mM MgCl 2 , and 40 mg/ml digitonin for 10 min, and the resulting lysates were centrifuged with 2,060 3 g for 10 min at 4 C. The supernatant was used for the cytosolic fraction. The pellets were washed, incubated with RIPA buffer at 4 C for 10 min and the nuclear fraction collected after centrifugation at 4 C for 10 min at 21,000 3 g.
(B) Forty-eight hours after transfecting the siRNAs shown, the relative interaction of lincRNA-p21 and CTNNB1 or JUNB mRNAs was studied by RIP analysis.
(C) RIP analysis of Rck interaction with CTNNB1 or JUNB mRNAs in cells expressing normal levels or silenced lincRNA-p21.
(D) WB analysis and densitometric quantification (top) and lincRNA-p21 RT-qPCR analysis (bottom) 48 hr after silencing Rck and/or HuR. (E and F) Forty-eight hours after transfecting the siRNAs shown, polysomes were prepared (E), and the relative distribution of CTNNB1, JUNB, and GAPDH mRNAs (F) was studied as explained in Bioinformatic Analysis of lincRNA-p21 Interaction Sites with mRNAs We used BLAST (http://blast.ncbi.nlm.nih.gov/) to identify local regions of sequence similarity between lincRNA-p21 (Supplemental Information) and CTNNB1 mRNA (NM_001904.3), JUNB mRNA (NM_002229.2), and GAPDH mRNA (NM_002046.3). The similarity regions with a length R20 bp, E value %210 and matching to the reverse complementary sequence of lincRNAp21 were selected as and considered as possible interaction regions through base-paring between lincRNA-p21 and each mRNA. Table S1 lists the putative interaction regions identified.
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